ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
拜瑪林製藥
59.33
+0.4600
0.78%
盤後:
59.50
0.1700
+0.29%
19:34 EDT
成交量:
193.76萬
成交額:
1.15億
市值:
114.67億
市盈率:
42.68
高:
59.35
開:
59.24
低:
58.61
收:
58.87
52周最高:
66.28
52周最低:
49.26
股本:
1.93億
流通股本:
1.92億
量比:
1.16
換手率:
1.01%
股息:
- -
股息率:
- -
每股收益(TTM):
1.39
每股收益(LYR):
1.80
淨資產收益率:
4.48%
總資產收益率:
4.49%
市淨率:
1.85
市盈率(LYR):
32.96
資料載入中...
總覽
公司
新聞
公告
美國食品藥品監督管理局受理拜瑪林製藥關於Voxzogo® (vosoritide)用於軟骨發育不全兒童完全批准的補充新藥申請
美股速递
·
07/13
熱門話題-BioMarin股價上漲,因其治療遺傳性疾病的藥物在臨牀試驗中達到主要目標
路透中文
·
05/21
BioMarin公司的藥物在晚期臨牀試驗中顯示出顯著的兒童生長促進作用
路透中文
·
05/21
拜瑪林製藥III期研究顯示第52周時年化生長速度增加2.33釐米/年
美股速递
·
05/21
拜瑪林製藥宣佈Voxzogo® (Vosoritide) 在軟骨發育不全兒童中取得積極三期關鍵研究結果
美股速递
·
05/21
美國研究綜述-CAVA集團、Eagle Materials、Vertiv控股
路透中文
·
05/20
美國研究綜述-CAVA集團、Eagle Materials、Vertiv控股
路透中文
·
05/20
基因療法後期試驗結果喜憂參半,拜瑪林製藥股價應聲下跌1%
美股速递
·
05/18
拜瑪林製藥ENERGY 3研究:放射學整體印象變化評分未現改善
美股速递
·
05/18
BioMarin的遺傳性疾病療法在後期研究中結果喜憂參半
路透中文
·
05/18
拜瑪林製藥:佝僂病嚴重程度評分與生長Z評分等次要終點未見積極趨勢
美股速递
·
05/18
拜瑪林製藥Bmn 401在ENERGY 3研究中顯示血漿無機焦磷酸鹽顯著增加
美股速递
·
05/18
拜瑪林製藥在兒科內分泌學會2026年會公佈Voxzogo長期治療對軟骨發育不全患兒臂展、骨骼健康及生長影響的新數據
美股速递
·
05/03
法國於2026年4月23日批准拜瑪林製藥與Amicus併購交易的外國直接投資許可 - 美國證券交易委員會文件披露
美股速递
·
04/24
BioMarin 停止骨病治療的中期試驗
路透中文
·
03/16
拜瑪林製藥:因兩項研究者發起試驗中發生多起股骨頭骨骺滑脱事件而決定終止研究
美股速递
·
03/16
拜瑪林製藥 - 繼續推進Voxzogo針對努南綜合徵和特發性矮小症的二期Canopy試驗 - 美國證監會文件披露
美股速递
·
03/16
美國FDA批准拜瑪林製藥Palynziq®(Pegvaliase-Pqpz)用於12歲及以上苯丙酮尿症青少年患者
美股速递
·
02/28
Ascendis治療侏儒症兒童的療法獲美國批准
路透中文
·
02/28
BridgeBio公司的口服藥物在後期研究中改善了侏儒症兒童的生長狀況
路透中文
·
02/12
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BMRN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMRN\",,,,,undefined,":{"symbol":"BMRN","market":"US","secType":"STK","nameCN":"拜瑪林製藥","latestPrice":59.33,"timestamp":1784923200000,"preClose":58.87,"halted":0,"volume":1937646,"hourTrading":{"tag":"盘后","latestPrice":59.5,"preClose":59.33,"latestTime":"19:34 EDT","volume":570520,"amount":33848972.78,"timestamp":1784936045022,"change":0.17,"changeRate":0.002865,"amplitude":0.002865},"delay":0,"changeRate":0.007813827076609494,"floatShares":192116189,"shares":193270028,"eps":1.39,"marketStatus":"休市中","change":0.46,"latestTime":"07-24 16:00:00 EDT","open":59.24,"high":59.35,"low":58.61,"amount":114676982.06436001,"amplitude":0.01257,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.39,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":932702400000,"exchange":"NASDAQ","adjPreClose":58.87,"preHourTrading":{"tag":"盘前","latestPrice":59.32,"preClose":58.87,"latestTime":"09:29 EDT","volume":639,"amount":37842.599844,"timestamp":1784899799999,"change":0.45,"changeRate":0.007644,"amplitude":0.058604},"postHourTrading":{"tag":"盘后","latestPrice":59.5,"preClose":59.33,"latestTime":"19:34 EDT","volume":570520,"amount":33848972.78,"timestamp":1784936045022,"change":0.17,"changeRate":0.002865,"amplitude":0.002865},"volumeRatio":1.1619958651768134,"impliedVol":0.5013,"impliedVolPercentile":0.9004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMRN\",,,,,undefined,":{"symbol":"BMRN","floatShares":192116189,"roa":"4.49%","roe":"4.48%","lyrEps":1.8,"volumeRatio":1.1619958651768134,"shares":193270028,"dividePrice":0,"high":59.35,"amplitude":0.01257,"preClose":58.87,"low":58.61,"week52Low":49.2592,"pbRate":"1.85","psRate":"3.54","week52High":66.275,"institutionHeld":0.9744,"latestPrice":59.33,"eps":1.39,"divideRate":0,"volume":1937646,"delay":0,"ttmEps":1.39,"open":59.24,"prevYearClose":59.43,"prevWeekClose":59.59,"prevMonthClose":57.22,"prevQuarterClose":57.22,"fiveDayClose":59.59,"twentyDayClose":57.35,"sixtyDayClose":53.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMRN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-04","symbol":"BMRN","fiscalQuarterEnding":"2026/03","expectedEps":0.78,"name":null,"time":"盤後","type":"earning","dateTimestamp":1777867200000,"reportTimeType":"post","actualEps":0.58},{"market":"US","date":"2026-02-23","symbol":"BMRN","fiscalQuarterEnding":"2025/12","expectedEps":0.07,"name":null,"time":"盤後","type":"earning","dateTimestamp":1771822800000,"reportTimeType":"post","actualEps":0.28},{"market":"US","date":"2025-10-27","symbol":"BMRN","fiscalQuarterEnding":"2025/09","expectedEps":0.82,"name":null,"time":"盤後","type":"earning","dateTimestamp":1761537600000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2025-08-04","symbol":"BMRN","fiscalQuarterEnding":"2025/06","expectedEps":0.8,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754280000000,"reportTimeType":"post","actualEps":1.25},{"market":"US","date":"2025-05-01","symbol":"BMRN","fiscalQuarterEnding":"2025/03","expectedEps":0.73,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"post","actualEps":0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMRN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMRN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2963,"buy":0.4815,"hold":0.2222,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4815,"analysts":27,"updateTime":1779336000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BMRN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BMRN","date":"2026-07-24","current":42.683453,"percent":0.427881,"low":-246.955768,"twenty":21.121991,"median":74.605374,"eighty":243.004654,"high":1069.125802,"avg":158.861857,"sd":252.159727,"marketCap":11378654865},"quantilePoints":[{"date":"2021-07-30","current":16.8013,"twenty":-144.931156,"median":-83.422231,"eighty":17.027349,"marketCap":14066283248},{"date":"2021-08-06","current":17.110693,"twenty":-144.931156,"median":-82.965863,"eighty":17.063524,"marketCap":14325311683},{"date":"2021-08-13","current":16.431784,"twenty":-144.931156,"median":-82.965863,"eighty":17.063524,"marketCap":13756919692},{"date":"2021-08-20","current":16.455874,"twenty":-144.931156,"median":-82.965863,"eighty":17.063524,"marketCap":13777088440},{"date":"2021-08-27","current":18.288928,"twenty":-144.931156,"median":-82.965863,"eighty":17.151762,"marketCap":15311746815},{"date":"2021-09-03","current":18.604292,"twenty":-144.931156,"median":-82.965863,"eighty":17.265235,"marketCap":15575774062},{"date":"2021-09-10","current":17.077843,"twenty":-144.931156,"median":-82.965863,"eighty":17.275493,"marketCap":14297808844},{"date":"2021-09-17","current":17.029662,"twenty":-144.931156,"median":-82.965863,"eighty":17.275493,"marketCap":14257471348},{"date":"2021-09-24","current":17.213624,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14411487243},{"date":"2021-10-01","current":16.89826,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14147459995},{"date":"2021-10-08","current":17.044992,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14270306006},{"date":"2021-10-15","current":16.620127,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":13914602631},{"date":"2021-10-22","current":16.14927,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":13520395283},{"date":"2021-10-29","current":913.742979,"twenty":-144.931156,"median":-82.965863,"eighty":17.356508,"marketCap":14544047003},{"date":"2021-11-05","current":967.9689,"twenty":-144.931156,"median":-82.965863,"eighty":17.405709,"marketCap":15407160981},{"date":"2021-11-12","current":942.70851,"twenty":-144.931156,"median":-82.965863,"eighty":17.560148,"marketCap":15005091360},{"date":"2021-11-19","current":1055.053805,"twenty":-144.931156,"median":-82.965863,"eighty":17.678992,"marketCap":16793291407},{"date":"2021-11-26","current":1010.184893,"twenty":-144.931156,"median":-82.965863,"eighty":17.719077,"marketCap":16079112949},{"date":"2021-12-03","current":956.780508,"twenty":-144.931156,"median":-82.965863,"eighty":17.763785,"marketCap":15229075350},{"date":"2021-12-10","current":979.157292,"twenty":-144.931156,"median":-82.965863,"eighty":17.780334,"marketCap":15585246612},{"date":"2021-12-17","current":997.497027,"twenty":-144.931156,"median":-82.965863,"eighty":17.854801,"marketCap":15877160172},{"date":"2021-12-23","current":1051.478133,"twenty":-144.931156,"median":-82.965863,"eighty":17.921454,"marketCap":16736377443},{"date":"2021-12-31","current":1019.0664,"twenty":-144.931156,"median":-82.965863,"eighty":18.068316,"marketCap":16220479893},{"date":"2022-01-07","current":971.77526,"twenty":-144.868574,"median":-82.756306,"eighty":18.102568,"marketCap":15467746814},{"date":"2022-01-14","current":1040.635774,"twenty":-144.868574,"median":-82.756306,"eighty":18.18902,"marketCap":16563799615},{"date":"2022-01-21","current":976.38903,"twenty":-144.868574,"median":-82.756306,"eighty":18.272526,"marketCap":15541184188},{"date":"2022-01-28","current":993.806011,"twenty":-144.868574,"median":-82.756306,"eighty":18.302,"marketCap":15818410273},{"date":"2022-02-04","current":1022.296039,"twenty":-144.868574,"median":-82.756306,"eighty":18.385092,"marketCap":16271886055},{"date":"2022-02-11","current":1048.594527,"twenty":-144.868574,"median":-82.756306,"eighty":18.50696,"marketCap":16690479084},{"date":"2022-02-18","current":978.811259,"twenty":-144.868574,"median":-82.756306,"eighty":18.612353,"marketCap":15579738809},{"date":"2022-02-25","current":-223.863547,"twenty":-146.720429,"median":-83.128851,"eighty":18.645295,"marketCap":14345176092},{"date":"2022-03-04","current":-219.184373,"twenty":-148.717362,"median":-83.543308,"eighty":18.645295,"marketCap":14045334603},{"date":"2022-03-11","current":-218.207922,"twenty":-159.853208,"median":-83.818061,"eighty":18.645295,"marketCap":13982763668},{"date":"2022-03-18","current":-234.549105,"twenty":-161.293219,"median":-83.967078,"eighty":18.645295,"marketCap":15029906670},{"date":"2022-03-25","current":-226.938537,"twenty":-162.185225,"median":-84.288399,"eighty":18.645295,"marketCap":14542221441},{"date":"2022-04-01","current":-227.656515,"twenty":-163.361234,"median":-84.633004,"eighty":18.645295,"marketCap":14588229481},{"date":"2022-04-08","current":-246.955768,"twenty":-164.641244,"median":-84.986921,"eighty":18.645295,"marketCap":15824925610},{"date":"2022-04-14","current":-238.225154,"twenty":-165.041247,"median":-85.857746,"eighty":18.645295,"marketCap":15265467837},{"date":"2022-04-22","current":-232.276832,"twenty":-165.973254,"median":-88.12096,"eighty":18.645295,"marketCap":14884299384},{"date":"2022-04-29","current":382.277246,"twenty":-166.445258,"median":-90.308931,"eighty":18.664196,"marketCap":15041462794},{"date":"2022-05-06","current":372.455987,"twenty":-166.445258,"median":-89.349626,"eighty":18.760072,"marketCap":14655025704},{"date":"2022-05-13","current":365.458317,"twenty":-166.445258,"median":-89.349626,"eighty":18.859197,"marketCap":14379688400},{"date":"2022-05-20","current":374.814577,"twenty":-166.445258,"median":-89.349626,"eighty":18.955948,"marketCap":14747829142},{"date":"2022-05-27","current":380.691624,"twenty":-166.445258,"median":-89.349626,"eighty":19.066512,"marketCap":14979073327},{"date":"2022-06-03","current":364.329924,"twenty":-166.445258,"median":-89.349626,"eighty":19.178673,"marketCap":14335289516},{"date":"2022-06-10","current":352.998976,"twenty":-166.445258,"median":-89.349626,"eighty":19.261875,"marketCap":13889450727},{"date":"2022-06-17","current":357.700614,"twenty":-166.445258,"median":-89.349626,"eighty":19.519294,"marketCap":14074446075},{"date":"2022-06-24","current":408.337255,"twenty":-166.509258,"median":-86.272203,"eighty":107.93637,"marketCap":16066845973},{"date":"2022-07-01","current":399.545192,"twenty":-166.509258,"median":-84.809963,"eighty":110.39574,"marketCap":15720904673},{"date":"2022-07-08","current":418.539809,"twenty":-166.509258,"median":-84.754081,"eighty":111.051374,"marketCap":16468285878},{"date":"2022-07-15","current":409.418632,"twenty":-166.509258,"median":-83.152135,"eighty":111.935442,"marketCap":16109394903},{"date":"2022-07-22","current":400.720602,"twenty":-166.509258,"median":-83.077626,"eighty":112.591077,"marketCap":15767153510},{"date":"2022-07-29","current":404.575945,"twenty":-166.509258,"median":-81.708522,"eighty":113.113211,"marketCap":15918849695},{"date":"2022-08-05","current":327.838991,"twenty":-166.509258,"median":-34.536978,"eighty":114.110012,"marketCap":17726254245},{"date":"2022-08-12","current":325.272938,"twenty":-166.509258,"median":-34.536978,"eighty":114.976279,"marketCap":17587507734},{"date":"2022-08-19","current":318.464838,"twenty":-166.509258,"median":-34.536978,"eighty":115.685314,"marketCap":17219393812},{"date":"2022-08-26","current":312.187472,"twenty":-166.509258,"median":-34.536978,"eighty":116.907582,"marketCap":16879976635},{"date":"2022-09-02","current":307.488024,"twenty":-166.509258,"median":-34.536978,"eighty":117.883617,"marketCap":16625877437},{"date":"2022-09-09","current":318.773561,"twenty":-166.509258,"median":-34.536978,"eighty":141.162306,"marketCap":17236086460},{"date":"2022-09-16","current":302.58276,"twenty":-166.509258,"median":-34.536978,"eighty":148.167383,"marketCap":16360649808},{"date":"2022-09-23","current":291.022801,"twenty":-166.509258,"median":-34.536978,"eighty":150.289725,"marketCap":15735602876},{"date":"2022-09-30","current":290.782684,"twenty":-166.509258,"median":-34.536978,"eighty":152.726136,"marketCap":15722619705},{"date":"2022-10-07","current":302.376944,"twenty":-166.509258,"median":-34.536978,"eighty":167.017841,"marketCap":16349521376},{"date":"2022-10-14","current":299.289715,"twenty":-166.509258,"median":-34.536978,"eighty":168.933976,"marketCap":16182594895},{"date":"2022-10-21","current":308.757218,"twenty":-166.509258,"median":-34.536978,"eighty":170.628042,"marketCap":16694502768},{"date":"2022-10-28","current":192.178834,"twenty":-166.509258,"median":-34.536978,"eighty":175.146289,"marketCap":16126110354},{"date":"2022-11-04","current":182.699459,"twenty":-166.509258,"median":-34.536978,"eighty":176.471621,"marketCap":15330676998},{"date":"2022-11-11","current":181.968573,"twenty":-166.509258,"median":-34.536978,"eighty":178.346579,"marketCap":15269346856},{"date":"2022-11-18","current":195.589638,"twenty":-166.509258,"median":-34.536978,"eighty":182.260927,"marketCap":16412317683},{"date":"2022-11-25","current":214.659129,"twenty":-166.509258,"median":-34.536978,"eighty":187.341695,"marketCap":18012476841},{"date":"2022-12-02","current":233.795065,"twenty":-166.509258,"median":-34.536978,"eighty":190.997361,"marketCap":19618211467},{"date":"2022-12-09","current":226.641237,"twenty":-166.509258,"median":-34.536978,"eighty":192.536436,"marketCap":19017919471},{"date":"2022-12-16","current":240.594523,"twenty":-166.509258,"median":-34.14536,"eighty":193.90401,"marketCap":20188767636},{"date":"2022-12-23","current":231.093,"twenty":-166.509258,"median":-33.835795,"eighty":195.798534,"marketCap":19391475791},{"date":"2022-12-30","current":229.210413,"twenty":-166.509258,"median":15.910621,"eighty":196.943179,"marketCap":19233504213},{"date":"2023-01-06","current":240.771708,"twenty":-166.509258,"median":15.99843,"eighty":199.747589,"marketCap":20203635549},{"date":"2023-01-13","current":249.653085,"twenty":-166.509258,"median":16.07919,"eighty":201.466427,"marketCap":20948889698},{"date":"2023-01-20","current":245.289915,"twenty":-166.509258,"median":16.188691,"eighty":202.812136,"marketCap":20582767336},{"date":"2023-01-27","current":259.730459,"twenty":-166.509258,"median":16.239185,"eighty":206.755441,"marketCap":21794502262},{"date":"2023-02-03","current":248.501386,"twenty":-166.509258,"median":16.333756,"eighty":220.240444,"marketCap":20852248263},{"date":"2023-02-10","current":242.432813,"twenty":-166.509258,"median":16.413891,"eighty":226.49506,"marketCap":20343022235},{"date":"2023-02-17","current":239.885785,"twenty":-166.509258,"median":16.442734,"eighty":229.440754,"marketCap":20129295983},{"date":"2023-02-24","current":226.065387,"twenty":-166.509258,"median":16.476957,"eighty":230.229225,"marketCap":18969598754},{"date":"2023-03-03","current":133.346847,"twenty":-166.509258,"median":16.516158,"eighty":230.229225,"marketCap":18876712940},{"date":"2023-03-10","current":119.234744,"twenty":-166.509258,"median":16.567292,"eighty":230.229225,"marketCap":16878989664},{"date":"2023-03-17","current":120.789579,"twenty":-166.509258,"median":16.617476,"eighty":230.229225,"marketCap":17099093629},{"date":"2023-03-24","current":119.564159,"twenty":-166.509258,"median":16.650384,"eighty":230.229225,"marketCap":16925621860},{"date":"2023-03-31","current":128.128926,"twenty":-166.445258,"median":16.685656,"eighty":229.9413,"marketCap":18138058956},{"date":"2023-04-06","current":127.246097,"twenty":-166.445258,"median":16.720301,"eighty":229.9413,"marketCap":18013084670},{"date":"2023-04-14","current":129.578349,"twenty":-166.509258,"median":16.77077,"eighty":230.229225,"marketCap":18343240618},{"date":"2023-04-21","current":127.575511,"twenty":-166.509258,"median":16.817229,"eighty":230.229225,"marketCap":18059716866},{"date":"2023-04-28","current":242.180022,"twenty":-166.509258,"median":16.855933,"eighty":231.407502,"marketCap":17343722249},{"date":"2023-05-05","current":250.17182,"twenty":-166.509258,"median":16.91578,"eighty":235.380867,"marketCap":17916054913},{"date":"2023-05-12","current":250.014562,"twenty":-166.573259,"median":16.941683,"eighty":237.019824,"marketCap":17904792857},{"date":"2023-05-19","current":241.732289,"twenty":-166.637259,"median":16.967171,"eighty":239.8282,"marketCap":17311657880},{"date":"2023-05-26","current":232.558885,"twenty":-166.637259,"median":17.014711,"eighty":240.585664,"marketCap":16654704583},{"date":"2023-05-30","current":231.916747,"twenty":-166.637259,"median":17.029662,"eighty":240.585664,"marketCap":16608717852},{"date":"2023-06-09","current":241.810918,"twenty":-166.73726,"median":17.061278,"eighty":241.008901,"marketCap":17317288908},{"date":"2023-06-16","current":251.194,"twenty":-166.74926,"median":17.112883,"eighty":241.385297,"marketCap":17989258281},{"date":"2023-06-23","current":250.591176,"twenty":-166.76126,"median":17.196104,"eighty":241.856963,"marketCap":17946087064},{"date":"2023-06-30","current":233.08308,"twenty":-166.76126,"median":17.241,"eighty":242.23058,"marketCap":16692244772},{"date":"2023-07-07","current":224.355242,"twenty":-166.76126,"median":17.308262,"eighty":242.23058,"marketCap":16067200635},{"date":"2023-07-14","current":224.643549,"twenty":-166.76126,"median":17.371372,"eighty":242.23058,"marketCap":16087847738},{"date":"2023-07-21","current":229.439928,"twenty":-166.76126,"median":17.48024,"eighty":242.23058,"marketCap":16431340462},{"date":"2023-07-28","current":226.871375,"twenty":-166.76126,"median":17.641098,"eighty":242.23058,"marketCap":16247393539},{"date":"2023-08-04","current":165.119407,"twenty":-166.76126,"median":17.695247,"eighty":242.23058,"marketCap":16510454583},{"date":"2023-08-11","current":171.085084,"twenty":-166.76126,"median":17.746561,"eighty":242.23058,"marketCap":17106968613},{"date":"2023-08-18","current":168.243389,"twenty":-166.76126,"median":17.778035,"eighty":242.23058,"marketCap":16822824706},{"date":"2023-08-25","current":175.281759,"twenty":-166.76126,"median":17.843539,"eighty":242.23058,"marketCap":17526598357},{"date":"2023-09-01","current":171.969585,"twenty":-166.76126,"median":17.901573,"eighty":242.23058,"marketCap":17195410756},{"date":"2023-09-08","current":170.162944,"twenty":-166.76126,"median":18.020515,"eighty":242.23058,"marketCap":17014762974},{"date":"2023-09-15","current":165.006492,"twenty":-166.76126,"median":18.09038,"eighty":242.23058,"marketCap":16499164096},{"date":"2023-09-22","current":162.352988,"twenty":-166.76126,"median":18.138595,"eighty":242.23058,"marketCap":16233837666},{"date":"2023-09-29","current":167.961101,"twenty":-166.76126,"median":18.255988,"eighty":242.23058,"marketCap":16794598490},{"date":"2023-10-06","current":164.272544,"twenty":-166.76126,"median":18.295251,"eighty":242.23058,"marketCap":16425775935},{"date":"2023-10-13","current":162.861106,"twenty":-166.76126,"median":18.372948,"eighty":242.23058,"marketCap":16284644855},{"date":"2023-10-20","current":155.427533,"twenty":-166.76126,"median":18.480739,"eighty":242.23058,"marketCap":15541354502},{"date":"2023-10-27","current":154.260745,"twenty":-166.76126,"median":18.544458,"eighty":242.382255,"marketCap":15424686142},{"date":"2023-11-03","current":102.060294,"twenty":-166.76126,"median":18.649124,"eighty":242.382255,"marketCap":15005006530},{"date":"2023-11-10","current":107.264835,"twenty":-166.76126,"median":18.746862,"eighty":242.382255,"marketCap":15770183276},{"date":"2023-11-17","current":111.736338,"twenty":-166.76126,"median":18.837592,"eighty":242.382255,"marketCap":16427588192},{"date":"2023-11-24","current":112.991947,"twenty":-166.76126,"median":18.922633,"eighty":242.382255,"marketCap":16612189000},{"date":"2023-12-01","current":116.69471,"twenty":-166.76126,"median":18.980092,"eighty":242.382255,"marketCap":17156573014},{"date":"2023-12-08","current":121.64027,"twenty":-166.76126,"median":19.115548,"eighty":242.331697,"marketCap":17883674154},{"date":"2023-12-15","current":125.073975,"twenty":-166.76126,"median":19.224871,"eighty":242.331697,"marketCap":18388500853},{"date":"2023-12-22","current":121.922141,"twenty":-166.76126,"median":19.421383,"eighty":242.331697,"marketCap":17925115152},{"date":"2023-12-29","current":124.446171,"twenty":-166.76126,"median":97.655587,"eighty":242.382255,"marketCap":18296200449},{"date":"2024-01-05","current":125.21491,"twenty":-166.76126,"median":106.724665,"eighty":242.432813,"marketCap":18409221351},{"date":"2024-01-12","current":122.998377,"twenty":-166.76126,"median":107.662485,"eighty":242.432813,"marketCap":18083344416},{"date":"2024-01-19","current":118.552498,"twenty":-166.79726,"median":109.532617,"eighty":242.575773,"marketCap":17429706862},{"date":"2024-01-26","current":116.91252,"twenty":-166.76126,"median":110.397223,"eighty":242.432813,"marketCap":17188595603},{"date":"2024-02-02","current":113.696625,"twenty":-166.76126,"median":111.153724,"eighty":242.432813,"marketCap":16715791494},{"date":"2024-02-09","current":112.940697,"twenty":-166.76126,"median":111.821225,"eighty":242.432813,"marketCap":16604654273},{"date":"2024-02-16","current":113.132882,"twenty":-166.76126,"median":112.099749,"eighty":242.432813,"marketCap":16632909499},{"date":"2024-02-23","current":101.214924,"twenty":-166.70126,"median":112.294622,"eighty":242.432813,"marketCap":16968175915},{"date":"2024-03-01","current":97.103598,"twenty":-165.901253,"median":112.199476,"eighty":242.382255,"marketCap":16278932666},{"date":"2024-03-08","current":96.664673,"twenty":-164.837246,"median":112.199476,"eighty":242.382255,"marketCap":16205349173},{"date":"2024-03-15","current":94.976502,"twenty":-164.11324,"median":112.199476,"eighty":242.382255,"marketCap":15922335740},{"date":"2024-03-22","current":94.661377,"twenty":-162.221226,"median":112.199476,"eighty":242.382255,"marketCap":15869506566},{"date":"2024-03-28","current":99.72589,"twenty":-162.081225,"median":112.199476,"eighty":242.382255,"marketCap":16718546865},{"date":"2024-04-05","current":97.790121,"twenty":-160.981216,"median":112.294622,"eighty":242.432813,"marketCap":16394024795},{"date":"2024-04-12","current":103.533211,"twenty":-131.648601,"median":112.294622,"eighty":242.432813,"marketCap":17356825158},{"date":"2024-04-19","current":101.959724,"twenty":-125.404689,"median":112.294622,"eighty":242.432813,"marketCap":17093037852},{"date":"2024-04-26","current":75.899547,"twenty":-124.450186,"median":112.199476,"eighty":242.382255,"marketCap":15593941332},{"date":"2024-05-03","current":77.447263,"twenty":-123.068927,"median":112.199476,"eighty":242.382255,"marketCap":15911927491},{"date":"2024-05-10","current":75.524945,"twenty":-121.619256,"median":112.199476,"eighty":242.382255,"marketCap":15516977501},{"date":"2024-05-17","current":71.135034,"twenty":-119.850332,"median":112.199476,"eighty":242.382255,"marketCap":14615048436},{"date":"2024-05-24","current":70.146149,"twenty":-118.560287,"median":112.199476,"eighty":242.382255,"marketCap":14411877047},{"date":"2024-05-31","current":69.37907,"twenty":-117.48525,"median":112.199476,"eighty":242.382255,"marketCap":14254276811},{"date":"2024-06-07","current":74.573027,"twenty":-116.644766,"median":112.199476,"eighty":242.382255,"marketCap":15321401304},{"date":"2024-06-14","current":77.179248,"twenty":-111.14579,"median":112.199476,"eighty":242.382255,"marketCap":15856862348},{"date":"2024-06-21","current":77.42878,"twenty":-109.718923,"median":112.294622,"eighty":242.432813,"marketCap":15908129895},{"date":"2024-06-28","current":76.088702,"twenty":-105.956293,"median":112.294622,"eighty":242.432813,"marketCap":15632804180},{"date":"2024-07-05","current":75.275413,"twenty":-104.685795,"median":112.294622,"eighty":242.432813,"marketCap":15465709954},{"date":"2024-07-12","current":78.574777,"twenty":15.974047,"median":112.294622,"eighty":242.432813,"marketCap":16143580851},{"date":"2024-07-19","current":77.715279,"twenty":16.07669,"median":112.294622,"eighty":242.432813,"marketCap":15966992634},{"date":"2024-07-26","current":78.177375,"twenty":16.188691,"median":112.294622,"eighty":242.432813,"marketCap":16061932535},{"date":"2024-08-02","current":77.81694,"twenty":16.239185,"median":112.294622,"eighty":242.432813,"marketCap":15987879412},{"date":"2024-08-09","current":65.768733,"twenty":16.333756,"median":112.294622,"eighty":242.432813,"marketCap":16875533342},{"date":"2024-08-16","current":66.429091,"twenty":16.413891,"median":112.294622,"eighty":242.432813,"marketCap":17044974053},{"date":"2024-08-23","current":66.792659,"twenty":16.442734,"median":112.294622,"eighty":242.432813,"marketCap":17138261636},{"date":"2024-08-30","current":67.67561,"twenty":16.477433,"median":112.294622,"eighty":242.432813,"marketCap":17364817194},{"date":"2024-09-06","current":62.385323,"twenty":16.516158,"median":112.294622,"eighty":242.432813,"marketCap":16007387673},{"date":"2024-09-13","current":62.993743,"twenty":16.567292,"median":112.294622,"eighty":242.432813,"marketCap":16163501587},{"date":"2024-09-20","current":52.450267,"twenty":16.617476,"median":112.294622,"eighty":242.432813,"marketCap":13458161687},{"date":"2024-09-27","current":52.36865,"twenty":16.650384,"median":112.294622,"eighty":242.432813,"marketCap":13437219576},{"date":"2024-10-04","current":51.574736,"twenty":16.689865,"median":112.294622,"eighty":242.432813,"marketCap":13233509957},{"date":"2024-10-11","current":52.197996,"twenty":16.740578,"median":112.294622,"eighty":242.432813,"marketCap":13393431527},{"date":"2024-10-18","current":52.019922,"twenty":16.78674,"median":112.294622,"eighty":242.432813,"marketCap":13347739650},{"date":"2024-10-25","current":51.737971,"twenty":16.823799,"median":112.294622,"eighty":242.432813,"marketCap":13275394178},{"date":"2024-11-01","current":39.383132,"twenty":16.89388,"median":112.294622,"eighty":242.432813,"marketCap":12692828865},{"date":"2024-11-08","current":39.661061,"twenty":16.92235,"median":112.294622,"eighty":242.432813,"marketCap":12782402883},{"date":"2024-11-15","current":37.502676,"twenty":16.946441,"median":112.294622,"eighty":242.432813,"marketCap":12086774874},{"date":"2024-11-22","current":37.9994,"twenty":16.977101,"median":112.294622,"eighty":242.432813,"marketCap":12246864608},{"date":"2024-11-29","current":39.046069,"twenty":17.029662,"median":112.294622,"eighty":242.432813,"marketCap":12584196546},{"date":"2024-12-06","current":39.465919,"twenty":17.060322,"median":112.294622,"eighty":242.432813,"marketCap":12719510487},{"date":"2024-12-13","current":39.034242,"twenty":17.110693,"median":112.294622,"eighty":242.432813,"marketCap":12580384886},{"date":"2024-12-20","current":38.827274,"twenty":17.196104,"median":112.294622,"eighty":242.432813,"marketCap":12513680830},{"date":"2024-12-27","current":39.55462,"twenty":17.220194,"median":112.294622,"eighty":242.432813,"marketCap":12748097940},{"date":"2025-01-03","current":39.519139,"twenty":17.307796,"median":112.294622,"eighty":242.432813,"marketCap":12736662959},{"date":"2025-01-10","current":39.844375,"twenty":17.365255,"median":112.389767,"eighty":242.575773,"marketCap":12841483618},{"date":"2025-01-17","current":36.385046,"twenty":17.450199,"median":112.389767,"eighty":242.575773,"marketCap":11726572974},{"date":"2025-01-24","current":36.503314,"twenty":17.562906,"median":112.389767,"eighty":242.575773,"marketCap":11764689577},{"date":"2025-01-31","current":37.467195,"twenty":17.680666,"median":112.389767,"eighty":242.575773,"marketCap":12075339893},{"date":"2025-02-07","current":37.804258,"twenty":17.732712,"median":112.389767,"eighty":242.575773,"marketCap":12183972212},{"date":"2025-02-14","current":38.34829,"twenty":17.773898,"median":112.389767,"eighty":242.575773,"marketCap":12359308587},{"date":"2025-02-21","current":30.500615,"twenty":17.780334,"median":112.389767,"eighty":242.575773,"marketCap":13019462069},{"date":"2025-02-28","current":31.803699,"twenty":17.85572,"median":112.389767,"eighty":242.575773,"marketCap":13575695020},{"date":"2025-03-07","current":32.281916,"twenty":18.006035,"median":112.415391,"eighty":242.718733,"marketCap":13779826465},{"date":"2025-03-14","current":31.034975,"twenty":18.081882,"median":112.415391,"eighty":242.718733,"marketCap":13247558490},{"date":"2025-03-21","current":31.839453,"twenty":18.118783,"median":112.415391,"eighty":242.718733,"marketCap":13590957184},{"date":"2025-03-28","current":31.92884,"twenty":18.238419,"median":112.415391,"eighty":242.718733,"marketCap":13629112594},{"date":"2025-04-04","current":26.932137,"twenty":18.288668,"median":112.415391,"eighty":242.718733,"marketCap":11496225153},{"date":"2025-04-11","current":25.524756,"twenty":18.312181,"median":112.389767,"eighty":242.575773,"marketCap":10895471939},{"date":"2025-04-17","current":26.580426,"twenty":18.41352,"median":112.389767,"eighty":242.575773,"marketCap":11346094238},{"date":"2025-04-25","current":28.435711,"twenty":18.53764,"median":112.415391,"eighty":242.718733,"marketCap":12138038961},{"date":"2025-05-02","current":22.707063,"twenty":18.58729,"median":112.139927,"eighty":242.718733,"marketCap":11895844499},{"date":"2025-05-09","current":21.546635,"twenty":18.58729,"median":111.745407,"eighty":242.718733,"marketCap":11287915641},{"date":"2025-05-16","current":21.696722,"twenty":18.58729,"median":111.057308,"eighty":242.718733,"marketCap":11366543664},{"date":"2025-05-23","current":21.235479,"twenty":18.58729,"median":110.374974,"eighty":242.718733,"marketCap":11124906326},{"date":"2025-05-30","current":21.433154,"twenty":18.58729,"median":109.878551,"eighty":242.718733,"marketCap":11228465185},{"date":"2025-06-06","current":20.232458,"twenty":18.58729,"median":107.994221,"eighty":242.718733,"marketCap":10599441004},{"date":"2025-06-13","current":20.968251,"twenty":18.58729,"median":106.858165,"eighty":242.718733,"marketCap":10984910091},{"date":"2025-06-20","current":20.221476,"twenty":18.578788,"median":103.589811,"eighty":242.861694,"marketCap":10593687734},{"date":"2025-06-27","current":19.804161,"twenty":18.578788,"median":102.118204,"eighty":242.861694,"marketCap":10375063476},{"date":"2025-07-03","current":21.048785,"twenty":18.578788,"median":101.959724,"eighty":242.861694,"marketCap":11027100737},{"date":"2025-07-11","current":21.531992,"twenty":18.578788,"median":100.329636,"eighty":242.861694,"marketCap":11280244615},{"date":"2025-07-18","current":21.367262,"twenty":18.578788,"median":98.296572,"eighty":242.861694,"marketCap":11193945566},{"date":"2025-07-25","current":21.876094,"twenty":18.578788,"median":97.790121,"eighty":242.861694,"marketCap":11460513740},{"date":"2025-08-01","current":21.176908,"twenty":18.578788,"median":97.373705,"eighty":242.861694,"marketCap":11094222220},{"date":"2025-08-08","current":17.371388,"twenty":18.507812,"median":96.664673,"eighty":242.861694,"marketCap":11417188175},{"date":"2025-08-15","current":16.944845,"twenty":18.385518,"median":95.392918,"eighty":242.861694,"marketCap":11136846858},{"date":"2025-08-22","current":16.965296,"twenty":18.302426,"median":84.240461,"eighty":242.861694,"marketCap":11150287880},{"date":"2025-08-29","current":16.851356,"twenty":18.272864,"median":78.68568,"eighty":242.861694,"marketCap":11075402185},{"date":"2025-09-05","current":16.579654,"twenty":18.18902,"median":78.265173,"eighty":243.004654,"marketCap":10896828606},{"date":"2025-09-12","current":16.334246,"twenty":18.103027,"median":78.177375,"eighty":242.861694,"marketCap":10735536341},{"date":"2025-09-19","current":16.109289,"twenty":18.073255,"median":77.853908,"eighty":242.861694,"marketCap":10587685099},{"date":"2025-09-26","current":15.373065,"twenty":17.971559,"median":77.548924,"eighty":242.861694,"marketCap":10103808304},{"date":"2025-10-03","current":16.234914,"twenty":17.854801,"median":77.170006,"eighty":242.861694,"marketCap":10670251377},{"date":"2025-10-10","current":15.732412,"twenty":17.780334,"median":76.412169,"eighty":242.861694,"marketCap":10339986263},{"date":"2025-10-17","current":15.469475,"twenty":17.763785,"median":75.98704,"eighty":242.861694,"marketCap":10167173122},{"date":"2025-10-24","current":15.936919,"twenty":17.724471,"median":75.626606,"eighty":242.861694,"marketCap":10474396484},{"date":"2025-10-31","current":19.162817,"twenty":17.719077,"median":74.776349,"eighty":242.861694,"marketCap":9972655597},{"date":"2025-11-07","current":19.136976,"twenty":17.728872,"median":74.573027,"eighty":242.861694,"marketCap":9959207592},{"date":"2025-11-14","current":20.015564,"twenty":17.770221,"median":74.573027,"eighty":242.861694,"marketCap":10416439731},{"date":"2025-11-21","current":19.373235,"twenty":17.797802,"median":74.573027,"eighty":242.861694,"marketCap":10082160773},{"date":"2025-11-28","current":20.646818,"twenty":17.854801,"median":74.573027,"eighty":242.861694,"marketCap":10744955259},{"date":"2025-12-05","current":19.867902,"twenty":17.971559,"median":74.573027,"eighty":242.861694,"marketCap":10339593994},{"date":"2025-12-12","current":19.561504,"twenty":18.073255,"median":74.573027,"eighty":242.861694,"marketCap":10180139088},{"date":"2025-12-19","current":19.177583,"twenty":18.080963,"median":74.573027,"eighty":242.861694,"marketCap":9980340170},{"date":"2025-12-26","current":22.208342,"twenty":18.080963,"median":74.573027,"eighty":242.861694,"marketCap":11557598935},{"date":"2026-01-02","current":21.93886,"twenty":18.080963,"median":74.573027,"eighty":242.861694,"marketCap":11417355463},{"date":"2026-01-09","current":22.278482,"twenty":18.080963,"median":74.573027,"eighty":242.861694,"marketCap":11594100660},{"date":"2026-01-16","current":20.329345,"twenty":18.110842,"median":74.573027,"eighty":242.861694,"marketCap":10579736924},{"date":"2026-01-23","current":21.108262,"twenty":18.110842,"median":74.573027,"eighty":242.861694,"marketCap":10985098189},{"date":"2026-01-30","current":21.038122,"twenty":18.193189,"median":74.573027,"eighty":242.861694,"marketCap":10948596464},{"date":"2026-02-06","current":21.097187,"twenty":18.283472,"median":74.573027,"eighty":242.861694,"marketCap":10979334759},{"date":"2026-02-13","current":22.127128,"twenty":18.296023,"median":74.573027,"eighty":242.861694,"marketCap":11515333779},{"date":"2026-02-20","current":23.411787,"twenty":18.447486,"median":74.573027,"eighty":242.861694,"marketCap":12183891696},{"date":"2026-02-27","current":33.681355,"twenty":18.682221,"median":74.573027,"eighty":242.861694,"marketCap":11751458561},{"date":"2026-03-06","current":33.387769,"twenty":18.886778,"median":74.573027,"eighty":242.861694,"marketCap":11649025854},{"date":"2026-03-13","current":32.560929,"twenty":19.024071,"median":74.573027,"eighty":242.861694,"marketCap":11360540816},{"date":"2026-03-20","current":30.333976,"twenty":19.128116,"median":74.573027,"eighty":242.861694,"marketCap":10583554445},{"date":"2026-03-27","current":30.620613,"twenty":19.179593,"median":74.573027,"eighty":242.861694,"marketCap":10683562592},{"date":"2026-04-02","current":31.552185,"twenty":19.246563,"median":74.573027,"eighty":242.861694,"marketCap":11008589069},{"date":"2026-04-10","current":31.034033,"twenty":19.403778,"median":74.573027,"eighty":242.861694,"marketCap":10827805111},{"date":"2026-04-17","current":29.821335,"twenty":19.489367,"median":74.573027,"eighty":242.861694,"marketCap":10404693721},{"date":"2026-04-24","current":29.755188,"twenty":19.677418,"median":74.573027,"eighty":242.861694,"marketCap":10381614918},{"date":"2026-05-01","current":29.862876,"twenty":19.799768,"median":74.573027,"eighty":242.861694,"marketCap":10419187209},{"date":"2026-05-08","current":38.921248,"twenty":19.878238,"median":74.573027,"eighty":242.861694,"marketCap":10459773915},{"date":"2026-05-15","current":38.288382,"twenty":20.070937,"median":74.573027,"eighty":242.861694,"marketCap":10289696290},{"date":"2026-05-22","current":38.909765,"twenty":20.166917,"median":74.573027,"eighty":242.861694,"marketCap":10456688095},{"date":"2026-05-29","current":37.931627,"twenty":20.241499,"median":74.605374,"eighty":243.004654,"marketCap":10193821260},{"date":"2026-06-05","current":40.614315,"twenty":20.395055,"median":74.573027,"eighty":242.861694,"marketCap":10914772213},{"date":"2026-06-12","current":39.945441,"twenty":20.583149,"median":74.573027,"eighty":242.861694,"marketCap":10735017686},{"date":"2026-06-18","current":39.571447,"twenty":20.703188,"median":74.573027,"eighty":242.861694,"marketCap":10634509778},{"date":"2026-06-26","current":41.247228,"twenty":20.787453,"median":74.605374,"eighty":243.004654,"marketCap":11084862519},{"date":"2026-07-02","current":41.585261,"twenty":20.891982,"median":74.605374,"eighty":243.004654,"marketCap":11175706205},{"date":"2026-07-10","current":43.131583,"twenty":20.968983,"median":74.605374,"eighty":243.004654,"marketCap":11591267746},{"date":"2026-07-17","current":43.153159,"twenty":21.042928,"median":74.605374,"eighty":243.004654,"marketCap":11597066280},{"date":"2026-07-24","current":42.340441,"twenty":21.121991,"median":74.605374,"eighty":243.004654,"marketCap":11378654865}],"updateTime":1785032344245},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMRN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1115162702","title":"美國食品藥品監督管理局受理拜瑪林製藥關於Voxzogo® (vosoritide)用於軟骨發育不全兒童完全批准的補充新藥申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1115162702","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115162702?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 21:18","pubTimestamp":1783948727,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)已正式受理拜玛林制药提交的补充新药申请,该申请旨在为药物Voxzogo® (vosoritide)在治疗儿童软骨发育不全症方面获得完全批准。此举标志着该药物在监管审批流程中迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMRN","IE00B19Z3581.USD","IE00B7SZLL34.SGD","BK4139","IE0002270589.USD","IE00B19Z3B42.SGD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637762331","title":"熱門話題-BioMarin股價上漲,因其治療遺傳性疾病的藥物在臨牀試驗中達到主要目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2637762331","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637762331?lang=zh_tw&edition=fundamental","pubTime":"2026-05-21 21:46","pubTimestamp":1779371166,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nL4S41Y1F0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","BK4566","BMRN","IE00B19Z3B42.SGD","BK4139","IE00B7SZLL34.SGD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637768958","title":"BioMarin公司的藥物在晚期臨牀試驗中顯示出顯著的兒童生長促進作用","url":"https://stock-news.laohu8.com/highlight/detail?id=2637768958","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637768958?lang=zh_tw&edition=fundamental","pubTime":"2026-05-21 05:16","pubTimestamp":1779311771,"startTime":"0","endTime":"0","summary":"BioMarin公司的药物在晚期临床试验中显示出显著的儿童生长促进作用路透5月20日 - BioMarin制药公司周三表示,其用于治疗一种导致身材矮小的罕见疾病的药物有助于促进儿童生长,达到了后期临床试验的主要目标,该消息推动其股价在盘后交易中上涨近5%。这项涉及80名患者的研究针对3至17岁的儿童进行了药物评估。目前,美国食品和药物管理局或欧洲药品管理局尚未批准任何针对该疾病的治疗方法,BioMarin表示。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4T41X20D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B19Z3581.USD","IE0002270589.USD","IE00B7SZLL34.SGD","BMRN","IE00B19Z3B42.SGD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127221100","title":"拜瑪林製藥III期研究顯示第52周時年化生長速度增加2.33釐米/年","url":"https://stock-news.laohu8.com/highlight/detail?id=1127221100","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127221100?lang=zh_tw&edition=fundamental","pubTime":"2026-05-21 04:21","pubTimestamp":1779308506,"startTime":"0","endTime":"0","summary":"拜玛林制药公司公布的一项III期临床试验数据显示,在治疗第52周时,患者的年化生长速度实现了显著提升,增幅达到2.33厘米/年。这一积极结果凸显了其在研疗法在促进生长方面的潜力,为后续的研发与审批进程提供了关键支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE00B7SZLL34.SGD","BMRN","IE0002270589.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151320774","title":"拜瑪林製藥宣佈Voxzogo® (Vosoritide) 在軟骨發育不全兒童中取得積極三期關鍵研究結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1151320774","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151320774?lang=zh_tw&edition=fundamental","pubTime":"2026-05-21 04:21","pubTimestamp":1779308486,"startTime":"0","endTime":"0","summary":"拜玛林制药公布了其药物Voxzogo® (Vosoritide) 针对软骨发育不全儿童患者的三期关键性研究的积极成果。该研究达到了主要终点,显示治疗取得了显著效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","BK4566","IE00B19Z3581.USD","BMRN","IE00B7SZLL34.SGD","IE0002270589.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636816228","title":"美國研究綜述-CAVA集團、Eagle Materials、Vertiv控股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636816228","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636816228?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 15:08","pubTimestamp":1779260900,"startTime":"0","endTime":"0","summary":"美国研究综述-CAVA集团、Eagle Materials、Vertiv控股路透5月20日 - 周三,华尔街的证券分析师们修订了多家在美国上市公司的评级和目标股价,其中包括CAVA集团、Eagle Materials和Vertiv控股。股票条目按字母顺序排列。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4T41X0MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2290526834.HKD","IE00B7SZLL34.SGD","IONS","LU2720916845.USD","THC","CAVA","IE00BMPRXR70.SGD","LU2249611893.SGD","HALO","INSM","LU2108987350.USD","MRNY","RLAY","VRTL","LU0882574055.USD","LU0878866978.SGD","HD","LU2462157665.USD","MRNA","LU0098860793.USD","LU2543165471.USD","INCY","LU0130103400.USD","IE00B1XK9C88.USD","UHS","BMRN","DRUG","LU0943347566.SGD","VRTX","LU1035775433.USD","BRO","BK4139","LU0868494708.USD","MRNX","BK4548","IE00BN0W2V16.EUR","EXP","CHRW","VRT","LU1989772840.SGD","BK4534","JAZZ","BK4585","IE0002270589.USD","MIRM","UTHR","ALNY","LU2065731478.USD","IE00BKPKM429.USD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636162238","title":"美國研究綜述-CAVA集團、Eagle Materials、Vertiv控股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636162238","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636162238?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 15:08","pubTimestamp":1779260900,"startTime":"0","endTime":"0","summary":"美国研究综述-CAVA集团、Eagle Materials、Vertiv控股路透5月20日 - 周三,华尔街的证券分析师们修订了多家在美国上市公司的评级和目标股价,其中包括CAVA集团、Eagle Materials和Vertiv控股。股票条目按字母顺序排列。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4S41X0MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1303367103.USD","MRNX","VRT","BK4534","LU2125909916.SGD","IE0002270589.USD","BRO","IE00BZ1G4Q59.USD","LU0942090050.USD","LU1551013342.USD","MIRM","BMRN","LU0079474960.USD","UTHR","IE00B7SZLL34.SGD","IONS","JAZZ","SG9999001440.SGD","HALO","UHS","IE0009355771.USD","LU2456880835.USD","LU0238689110.USD","BK4568","VRTX","IE00B1XK9C88.USD","ALNY","LU0878866978.SGD","INSM","CHRW","THC","LU1929549753.HKD","IE00B19Z9P08.USD","LU2362541513.USD","EXP","BK4209","HD","INCY","LU0823414551.USD","BK4083","LU0868494617.USD","MRNY","MRNA","LU0061475181.USD","RLAY","LU1035775433.USD","BK4501","CAVA","VRTL","DRUG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101027296","title":"基因療法後期試驗結果喜憂參半,拜瑪林製藥股價應聲下跌1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1101027296","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101027296?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 21:47","pubTimestamp":1779112039,"startTime":"0","endTime":"0","summary":"拜玛林制药(Biomarin Pharmaceutical)一项针对遗传性疾病的疗法在后期研究中呈现出复杂的数据结果,市场对此反应审慎,公司股价应声下跌约1%。\n这项关键临床试验的结果未能提供明确一致的成功信号,导致投资者信心受挫。尽管疗法在某些评估指标上显示出积极潜力,但整体数据的混合性引发了对其最终疗效与商业化前景的重新评估。\n股价的即时波动反映了市场对生物科技公司研发管线不确定性的典型定价行为。在高度依赖单一或少数重磅产品驱动的行业里,临床数据的任何模糊性都可能迅速转化为资本市场的压力。此次下跌凸显了在创新疗法开发过程中,从科学验证到市场接纳所面临的严峻挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMRN","BK4139","IE00B19Z3B42.SGD","IE0002270589.USD","BK4566","IE00B19Z3581.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184770893","title":"拜瑪林製藥ENERGY 3研究:放射學整體印象變化評分未現改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1184770893","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184770893?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 21:11","pubTimestamp":1779109895,"startTime":"0","endTime":"0","summary":"拜玛林制药公司近日公布的ENERGY 3研究结果显示,其评估指标——放射学整体印象变化评分——并未出现具有统计学意义的改善。这一核心数据未能达到研究预设的终点,引发了市场对该疗法潜在疗效的进一步审视。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4139","IE00B19Z3581.USD","IE0002270589.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","BMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636076991","title":"BioMarin的遺傳性疾病療法在後期研究中結果喜憂參半","url":"https://stock-news.laohu8.com/highlight/detail?id=2636076991","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636076991?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 21:09","pubTimestamp":1779109785,"startTime":"0","endTime":"0","summary":"BioMarin的遗传性疾病疗法在后期研究中结果喜忧参半路透5月18日 - BioMarin制药公司 BMRN.O 周一表示,其针对一种罕见遗传性疾病的实验性疗法在晚期临床试验中达到了两大主要目标之一。 (为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nL4S41V16I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE0002270589.USD","IE00B19Z3581.USD","BMRN","BK4139","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198173165","title":"拜瑪林製藥:佝僂病嚴重程度評分與生長Z評分等次要終點未見積極趨勢","url":"https://stock-news.laohu8.com/highlight/detail?id=1198173165","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198173165?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 21:07","pubTimestamp":1779109622,"startTime":"0","endTime":"0","summary":"拜玛林制药公司近日公布的数据显示,其研究中的关键次要终点,包括佝偻病严重程度评分与生长Z评分,均未观察到积极的改善趋势。\n这一结果引发了市场对其相关疗法前景的进一步审视。分析人士指出,次要终点的表现对于全面评估治疗效果至关重要,当前数据的缺乏亮点可能意味着需要更深入的分析或更长的观察周期。\n公司方面尚未就这些具体数据发表进一步评论。投资者正密切关注后续可能披露的更多细节,以评估其对整体研发管线价值的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BMRN","IE00B19Z3B42.SGD","IE0002270589.USD","IE00B7SZLL34.SGD","BK4566","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186367310","title":"拜瑪林製藥Bmn 401在ENERGY 3研究中顯示血漿無機焦磷酸鹽顯著增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1186367310","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186367310?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 21:06","pubTimestamp":1779109609,"startTime":"0","endTime":"0","summary":"拜玛林制药公司宣布,其候选药物Bmn 401在ENERGY 3研究中的数据显示,能够显著提升患者血浆中的无机焦磷酸盐水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMRN","IE00B7SZLL34.SGD","IE00B19Z3581.USD","IE0002270589.USD","IE00B19Z3B42.SGD","BK4139","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192554879","title":"拜瑪林製藥在兒科內分泌學會2026年會公佈Voxzogo長期治療對軟骨發育不全患兒臂展、骨骼健康及生長影響的新數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1192554879","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192554879?lang=zh_tw&edition=fundamental","pubTime":"2026-05-03 03:30","pubTimestamp":1777750216,"startTime":"0","endTime":"0","summary":"拜玛林制药于儿科内分泌学会2026年度会议上,公布了关于Voxzogo长期治疗对软骨发育不全患儿臂展、骨骼健康及生长影响的最新研究数据。该研究深入探讨了Vosoritide持续用药对患儿多项生理指标产生的积极效果。\n最新分析结果显示,长期接受Voxzogo治疗的患儿在臂展发育、骨骼健康指标及整体生长参数方面均表现出显著改善。这些发现为Vosoritide在改善软骨发育不全患儿生活质量方面的长期疗效提供了重要临床证据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B19Z3581.USD","IE0002270589.USD","IE00B7SZLL34.SGD","BMRN","IE00B19Z3B42.SGD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199541668","title":"法國於2026年4月23日批准拜瑪林製藥與Amicus併購交易的外國直接投資許可 - 美國證券交易委員會文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1199541668","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199541668?lang=zh_tw&edition=fundamental","pubTime":"2026-04-24 04:24","pubTimestamp":1776975857,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会(SEC)最新公开的文件显示,法国监管机构已于2026年4月23日正式批准了拜玛林制药(Biomarin Pharmaceutical Inc)与Amicus Therapeutics之间并购案的外国直接投资(FDI)许可。\n此项关键监管许可的获取,标志着这起备受业界关注的生物制药企业合并案清除了一个重要监管障碍。两家公司在罕见病治疗领域均拥有领先技术平台和产品管线,此次整合将创造显著的协同效应。\n跨国并购交易中的外国投资审查是确保交易符合各国国家安全和经济利益的重要环节。法国当局的放行为该交易后续完成其他司法管辖区的审批程序奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE00B19Z3B42.SGD","BMRN","BK4139","IE00B7SZLL34.SGD","IE0002270589.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619669154","title":"BioMarin 停止骨病治療的中期試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2619669154","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619669154?lang=zh_tw&edition=fundamental","pubTime":"2026-03-16 21:34","pubTimestamp":1773668096,"startTime":"0","endTime":"0","summary":"路透3月16日 - BioMarin制药公司BMRN.O周一表示,在收到几例患者髋关节滑脱的报告后,该公司将停止其骨病治疗药物的中期试验,导致其股价下跌4%。BioMarin正在特纳综合征、SHOX缺陷和Aggrecan 缺陷患者中测试其药物Voxzogo。BioMarin表示,它将继续在患有努南综合征的患者和患有不明原因身材矮小的患者中测试这种药物。上个月,美国食品和药物管理局批准了 Ascendis Pharma公司的A71.F每周一次的注射剂Yuviwel,使其成为美国批准的第二种治疗软骨发育不全症的药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nL4S40417E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130102774.USD","ASND","BK4585","LU1201861249.SGD","IE00B7SZLL34.SGD","LU1699723380.USD","BK4559","LU0130517989.USD","BK4588","IE00B19Z3B42.SGD","LU0889565916.HKD","BK4566","IE00B19Z3581.USD","IE0002270589.USD","LU0648001328.SGD","LU0980610538.SGD","BK4139","LU0109394709.USD","BK","BMRN","LU0320765992.SGD","LU1571399168.USD","LU0477156953.USD","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157902853","title":"拜瑪林製藥:因兩項研究者發起試驗中發生多起股骨頭骨骺滑脱事件而決定終止研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1157902853","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157902853?lang=zh_tw&edition=fundamental","pubTime":"2026-03-16 20:35","pubTimestamp":1773664512,"startTime":"0","endTime":"0","summary":"拜玛林制药宣布,由于两项正在进行的研究者发起试验中出现了数例股骨头骨骺滑脱事件,公司已决定终止这些研究项目。该决定基于对患者安全的审慎评估,旨在优先保障临床试验参与者的福祉。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","BK4566","BMRN","IE00B19Z3B42.SGD","BK4139","IE00B7SZLL34.SGD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162043739","title":"拜瑪林製藥 - 繼續推進Voxzogo針對努南綜合徵和特發性矮小症的二期Canopy試驗 - 美國證監會文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1162043739","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162043739?lang=zh_tw&edition=fundamental","pubTime":"2026-03-16 20:34","pubTimestamp":1773664499,"startTime":"0","endTime":"0","summary":"根据美国证监会最新披露的文件,拜玛林制药宣布其针对努南综合征及特发性矮小症的二期临床试验“Canopy”将继续推进。该试验主要评估药物Voxzogo在相关适应症中的疗效与安全性。努南综合征和特发性矮小症均为影响儿童生长发育的罕见疾病,目前治疗选择有限。Voxzogo若最终获批,有望为相关患者提供新的治疗路径。拜玛林制药在罕见病药物研发领域具备丰富经验,此次试验的持续推进也进一步巩固了其在生长障碍治疗方向的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE00B7SZLL34.SGD","BMRN","IE0002270589.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193403909","title":"美國FDA批准拜瑪林製藥Palynziq®(Pegvaliase-Pqpz)用於12歲及以上苯丙酮尿症青少年患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1193403909","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193403909?lang=zh_tw&edition=fundamental","pubTime":"2026-02-28 09:03","pubTimestamp":1772240600,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)已正式批准拜玛林制药(Biomarin Pharmaceutical)旗下药物Palynziq®(Pegvaliase-Pqpz)用于治疗12岁及以上的苯丙酮尿症(PKU)青少年患者。这一批准标志着该药物适用人群的扩展,为更年轻的PKU患者提供了新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","BK4566","BMRN","IE00B19Z3581.USD","BK4139","IE0002270589.USD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614893869","title":"Ascendis治療侏儒症兒童的療法獲美國批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2614893869","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614893869?lang=zh_tw&edition=fundamental","pubTime":"2026-02-28 07:01","pubTimestamp":1772233283,"startTime":"0","endTime":"0","summary":"Ascendis治疗侏儒症儿童的疗法获美国批准路透2月27日 - 美国食品和药物管理局周五 批准了Ascendis Pharma公司的A71.F疗法,该疗法每周一次,用于治疗患有导致侏儒症的罕见遗传性疾病的儿童,该公司表示。(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nL4T3ZN27G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","LU1201861249.SGD","BMRN","LU0648001328.SGD","BK4135","LU0477156953.USD","BK4505","LU1699723380.USD","IE0002270589.USD","LU1571399168.USD","LU0980610538.SGD","BBIO","BK4139","BK4559","IE00B19Z3B42.SGD","LU0130102774.USD","BK","IE00B19Z3581.USD","BK4585","BK4588","BK4566","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610196925","title":"BridgeBio公司的口服藥物在後期研究中改善了侏儒症兒童的生長狀況","url":"https://stock-news.laohu8.com/highlight/detail?id=2610196925","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610196925?lang=zh_tw&edition=fundamental","pubTime":"2026-02-12 20:30","pubTimestamp":1770899429,"startTime":"0","endTime":"0","summary":"BridgeBio公司的口服药物在后期研究中改善了侏儒症儿童的生长状况路透2月12日 - BridgeBio制药公司BBIO.O周四称,根据一项晚期研究的结果,该公司的实验性疗法提高了 一种罕见遗传病儿童的生长速度,这种病会导致侏儒症。BridgeBio公司表示,该药物没有出现严重的副作用。目前,BioMarin Pharmaceutical公司的BMRN.O注射疗法Voxzogo是唯一 获准治疗该病的药物。该公司表示,如果获得批准,infigratinib将成为首个治疗软骨发育不全的口服药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nL4T3Z819S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","BK4588","BK4585","IE00B19Z3581.USD","IE00B7SZLL34.SGD","BBIO","IE0002270589.USD","BMRN","BK4139","BK4566","BK4505"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}]}}